Please use this identifier to cite or link to this item:
http://archive.cmb.ac.lk:8080/xmlui/handle/70130/3393
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | De Zoysa, M.I.M. | |
dc.contributor.author | Samarasekera, D.N. | |
dc.contributor.author | Senarath, L.D.J.U. | |
dc.contributor.author | Samarasekera, C.A. | |
dc.contributor.author | Reid, C.B. | |
dc.contributor.author | Lokuhetty, M.D.S. | |
dc.date.accessioned | 2012-12-20T07:55:09Z | |
dc.date.available | 2012-12-20T07:55:09Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Annual Research Symposium | en_US |
dc.identifier.uri | http://archive.cmb.ac.lk:8080/xmlui/handle/70130/3393 | - |
dc.description.abstract | Colon carcinoma has a worldwide incidence of over one million with a 5 year survival rate of <20% for metastatic disease. Identification of metastasis related biomarkers will enable risk evaluation of metastasis in colon carcinoma. | |
dc.language.iso | en | en_US |
dc.title | Pathological significance of Epidermal Growth Factor Receptor (EGFR), Vascular Endothelial Growth Factor (VEGF), Chemokine Receptor 4 (CXCR4) and Vimentin expression by colon carcinoma cells | en_US |
dc.type | Research abstract | en_US |
Appears in Collections: | Medicine |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
AnnualResearchSymposium2012UniversityofColombo.241.pdf | 22.83 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.